JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB125633

Recombinant human PI3K (p110 delta/p85 alpha) protein (Active)

Be the first to review this product! Submit a review

|

(8 Publications)

Recombinant human PI3K (p110 delta/p85 alpha) protein (Active) is a Human Full Length protein, in the 2 to 724 aa range, expressed in Baculovirus infected Sf9 cells, with >75%, suitable for SDS-PAGE, WB, FuncS.

View Alternative Names

GRB1, PIK3R1, Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha, Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha, PI3-kinase subunit delta, PI3K-delta, PI3Kdelta, PtdIns-3-kinase subunit delta, PtdIns-3-kinase subunit p110-delta, p110delta, PIK3CD

2 Images
Functional Studies - Recombinant human PI3K (p110 delta/p85 alpha) protein (Active) (AB125633)
  • FuncS

Supplier Data

Functional Studies - Recombinant human PI3K (p110 delta/p85 alpha) protein (Active) (AB125633)

The specific activity of ab125633 was equivalent to 2,514 nmol/min/mg as per activity assay protocol.

SDS-PAGE - Recombinant human PI3K (p110 delta/p85 alpha) protein (Active) (AB125633)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant human PI3K (p110 delta/p85 alpha) protein (Active) (AB125633)

Purity of ab125633 was determined to be >75% by densiometry.

Key facts

Purity

>75% Densitometry

Expression system

Baculovirus infected Sf9 cells

Tags

Tag free

Applications

SDS-PAGE, FuncS, WB

applications

Biologically active

Yes

Biological activity

The specific activity of ab125633 was equivalent to 2,514 nmol/min/mg as per activity assay protocol.

Accession

P27986

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 7 Preservative: 1.02% Imidazole Constituents: 25% Glycerol (glycerin, glycerine), 1.74% Sodium chloride, 0.82% Sodium phosphate, 0.004% (R*,R*)-1,4-Dimercaptobutan-2,3-diol, 0.002% PMSF

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "FuncS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Kinase assay.

Sequence info

[{"sequence":"","proteinLength":"Full Length","predictedMolecularWeight":"86 kDa","actualMolecularWeight":null,"aminoAcidEnd":724,"aminoAcidStart":2,"nature":"Recombinant","expressionSystem":null,"accessionNumber":"P27986","tags":[{"tag":"His","terminus":"N-Terminus"}]},{"sequence":"","proteinLength":"Full Length","predictedMolecularWeight":"111 kDa","actualMolecularWeight":null,"aminoAcidEnd":1044,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":null,"accessionNumber":"O00329","tags":[{"tag":"His","terminus":"N-Terminus"}]}]

Properties and storage information

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
True

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PI3K (p110 delta/p85 alpha) also known as phosphoinositide 3-kinase delta and alpha is composed of two subunits: the catalytic p110 delta and the regulatory p85 alpha. The complex has a molecular mass of about 124 kDa for p110 delta and 83 kDa for p85 alpha. PI3K is mainly expressed in leukocytes where it plays roles in immune responses. Its activity involves phosphorylation of phosphoinositides at the 3-position of the inositol ring acting as an important player in signal transduction.
Biological function summary

PI3K influences cell growth survival and metabolism by producing lipid second messengers. It partners with other PI3K proteins including p85 PI3K forming heterodimeric complexes. PI3K delta is important in hematopoietic cells promoting cellular responses to stimuli and modulating immune system activity. Dysfunction in these activities can lead to immune system disorders. The dual role of PI3K in both regulating normal cellular processes and contributing to pathologies makes it an attractive therapeutic target.

Pathways

PI3K is a central component of the PI3K/AKT signaling pathway which is significant in mediating cellular proliferation and survival. This pathway interacts with other signaling molecules such as the mTOR pathway to manage cellular growth and metabolism. PI3K works closely with proteins like PTEN a phosphatase that negatively regulates the pathway and AKT a downstream effector. Understanding these interactions highlights their importance in maintaining cellular homeostasis and exploring therapeutic strategies.

Dysregulation of PI3K activity links to cancer and inflammatory diseases. In cancer mutations or overexpression of PI3K delta can lead to uncontrolled cell proliferation. Targeting PI3K with inhibitors offers potential for cancer treatment. In inflammatory disorders altered PI3K signaling can result in abnormal immune responses suggesting its role in diseases like rheumatoid arthritis. Researchers focus on modulating PI3K activity to develop treatments for these conditions particularly addressing its interactions with proteins like mTOR and PTEN.

Specifications

Form

Liquid

Additional notes

Affinity purified.

General info

Function

Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling (PubMed : 17626883, PubMed : 19805105, PubMed : 7518429). Modulates the cellular response to ER stress by promoting nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement (PubMed : 20348923).

Sequence similarities

Belongs to the PI3K p85 subunit family.

Post-translational modifications

Polyubiquitinated in T-cells by CBLB; which does not promote proteasomal degradation but impairs association with CD28 and CD3Z upon T-cell activation.. In adipose tissue, polyubiquitinated by the BCR(KBTBD2) E3 ubiquitin ligase complex; recognized by KBTBD2 through the SH2 domains, undergoes 'Lys-48'-linked polyubiquitination leading to its degradation.. Phosphorylated. Tyrosine phosphorylated in response to signaling by FGFR1, FGFR2, FGFR3 and FGFR4. Phosphorylated by CSF1R. Phosphorylated by ERBB4. Phosphorylated on tyrosine residues by TEK/TIE2. Dephosphorylated by PTPRJ. Phosphorylated by PIK3CA at Ser-608; phosphorylation is stimulated by insulin and PDGF. The relevance of phosphorylation by PIK3CA is however unclear (By similarity). Phosphorylated in response to KIT and KITLG/SCF. Phosphorylated by FGR.

Product protocols

Target data

Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling (PubMed : 17626883, PubMed : 19805105, PubMed : 7518429). Modulates the cellular response to ER stress by promoting nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement (PubMed : 20348923).
See full target information PIK3R1

Additional targets

PIK3CD

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Stem cells international 2022:5609501 PubMed36277041

2022

MFG-E8 Exerts Neuroprotection in Neural Stem Cells Induced by Anesthetic Sevoflurane via Regulating the PI3K/AKT Pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Minmin Cai,Liufang Sheng

Frontiers in neurology 12:653341 PubMed34413821

2021

LncRNA GAS5 as miR-26a-5p Sponge Regulates the PTEN/PI3K/Akt Axis and Affects Extracellular Matrix Synthesis in Degenerative Nucleus Pulposus Cells .

Applications

Unspecified application

Species

Unspecified reactive species

Liang Tan,Yifang Xie,Ye Yuan,Kai Hu

Frontiers in molecular neuroscience 13:95 PubMed32714145

2020

LncRNA LINC00641 Sponges miR-497-5p to Ameliorate Neural Injury Induced by Anesthesia via Up-Regulating BDNF.

Applications

Unspecified application

Species

Unspecified reactive species

Qingxia Chen,Jingjia Yan,Wenji Xie,Wenqin Xie,Meijun Li,Yanle Ye

The Journal of biological chemistry 295:8236-8251 PubMed32358062

2020

Transforming growth factor β (TGF-β) receptor signaling regulates kinase networks and phosphatidylinositol metabolism during T-cell activation.

Applications

Unspecified application

Species

Unspecified reactive species

Richard T Cattley,Mijoon Lee,William C Boggess,William F Hawse

Molecular medicine reports 20:1187-1195 PubMed31173235

2019

Alisol B 23‑acetate inhibits the viability and induces apoptosis of non‑small cell lung cancer cells via PI3K/AKT/mTOR signal pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Liu,Xi-Chao Xia,Liu-Yang Meng,Yu Wang,Yue-Mei Li

Molecular medicine reports 19:3658-3666 PubMed30896875

2019

Knockdown of serpin peptidase inhibitor clade C member 1 inhibits the growth of nasopharyngeal carcinoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jin Xu,Yin Ying,Gaoyun Xiong,Liqin Lai,Qingliang Wang,Yue Yang

Oncology letters 15:9377-9384 PubMed29928334

2018

Inhibition of the PI3K/Akt signaling pathway reverses sorafenib-derived chemo-resistance in hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Zhang,Qingqing Wang,Jun Liu,Haoqiang Cao

Oncology research 26:869-878 PubMed29212574

2017

Overexpression of Long Noncoding RNA PTENP1 Inhibits Cell Proliferation and Migration via Suppression of miR-19b in Breast Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Xianbiao Shi,Xiaoqiao Tang,Lei Su
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com